Use of heterologous expression systems to study autoimmune drug-induced hepatitis.
Lecoeur
S
S
CHU NECKER-INSERM U 75, Biochemie Pharmacologique et Métabolique, Université René Descartes, Paris, France.
Gautier
J C
JC
Belloc
C
C
Gauffre
A
A
Beaune
P H
PH
D001323:Autoantibodies / Q000302:isolation & purification; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000276:immunology / Q000378:metabolism; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000276:immunology / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism*; D004926:Escherichia coli / Q000235:genetics; D015870:Gene Expression; D006801:Humans; D066298:In Vitro Techniques; D008954:Models, Biological; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000235:genetics; D013989:Ticrynafen / Q000378:metabolism
D001323:Autoantibodies; D011994:Recombinant Proteins; D003577:Cytochrome P-450 Enzyme System; D013989:Ticrynafen